Anionic Drug Delivery
with 
Precision & Efficiency

     high cell transfection / cell entry without associated toxicity

     self-assembly with almost any anionic therapeutic cargo

     consistent and stable nanoparticles allow scale-up

     non-immunogenic nanoparticles allow repeated dosing

     protection of drug cargo while increasing circulatory half-life

     demonstrated formulation lyophilsation and scale-up

     strong IP protection as the only peptide drug delivery system

RALA represents a revolution in nanoparticle therapeutic delivery by starting with peptides. 

 

RALA peptide nanoparticles have many advantages:

 

 

 

 

All you need to know is that RALA is a 30 amino acid, pH responsive, cationic, secondary amphipathic, helical, conditional cell penetrating peptide.  In other words... one peptide with all the functions needed for a revolution in drug delivery!

Learn more by clicking below on one of our informative and downloadable files.

Click here

to learn more

Learn About

RALA Nanoparticles 

Learn About Cargo

and Tissue Capabilities

Learn About

Tumour Targeting 

Small    //    Stable   //   Self-Assembling

RALA Peptide : POSITIVE CHARGES

1/8

Drug Cargo : NEGATIVE CHARGES

(e.g. DNA, RNA, or Small Molecules)

SELF-ASSEMBLY OF ION PAIRS

Forms Consistent & Stable Nanoparticles

Regardless of Cargo Type

Z-Average

< 100 nm

© 2019 by pHion Therapeutics Ltd.

  • Twitter - White Circle
  • Facebook - White Circle
  • LinkedIn - White Circle

pHion Therapeutics Ltd.

School of Pharmacy

Medical Biology Centre

97 Lisburn Road 

Belfast

BT9 7BL

United Kingdom